COVID-19 UPDATE: We are open! Our team is working and offering consultations via phone, e-mail, and video conferencing.

TEXT US NOW - (901) 526-2126 

Long-term Actos Use Linked to Bladder Cancer

In June 2011, the Food and Drug Administration (FDA) warned that the use of Actos over an extended period of time may cause bladder cancer. Use of the dangerous & defective drug was discontinued in France and Germany, but not in the United States.

The warning followed a 2010 study that revealed an increased likelihood of developing bladder cancer in those who had taken Actos for a year or more. With the warning, Actos joins a growing list of known dangerous & defective drugs once thought to help patients, but later found to harm them.

Actos was intended to help people with type II diabetes control blood sugar levels. According to, the drug helps your body use insulin more efficiently and stops the production of excess sugar by the liver.

A mix of recommendations has been made regarding the continued prescription and use of Actos. Additional labeling of the diabetes drug to include a warning of the possible risk of bladder cancer to health care professionals has been suggested. The FDA approved updated labeling in 2011 that includes warnings against prescribing the drug to people with bladder cancer or with a family history of bladder cancer.

For many who’ve used Actos and already developed bladder cancer, the warnings come too late. The diabetes drug has been around since 1999. Some are fighting back, using the drug’s manufacturer Takeda Pharmaceuticals for producing and marketing a dangerous drug.

Additional side effects of the dangerous & defective diabetes drug Actos include headache, muscle pains, changes in or loss of vision, painful urination and discolored urine and abdominal cramping.